Relationship Between Overweight and Obesity with Hospitalization for Heart Failure in 20,985 Patients with Type 1 Diabetes: a Population-based Study from the Swedish National Diabetes Registry
Overview
Authors
Affiliations
Objective: To investigate the potential relationship between overweight, obesity, and severe obesity and the risk of hospitalization for heart failure (HF) in patients with type 1 diabetes.
Research Design And Methods: We studied patients with type 1 diabetes included in the Swedish National Diabetes Registry during 1998-2003, and they were followed up until hospitalization for HF, death, or 31 December 2009. Cox regression was used to estimate relative risks.
Results: In a sample of 20,985 type 1 diabetic patients (mean age, 38.6 years; mean BMI, 25.0 kg/m(2)), 635 patients were hospitalized with HF as a primary or secondary diagnosis during a median follow-up of 9.1 years. Cox regression adjusting for age, sex, diabetes duration, smoking, HbA1c, systolic and diastolic blood pressures, and baseline and intercurrent comorbidities (including myocardial infarction) showed a significant relationship between BMI and hospitalization for HF (P < 0.0001). In reference to patients in the BMI 20-25 kg/m(2) category, hazard ratios (HRs) were as follows: HR 1.22 (95% CI, 0.83-1.78) for BMI <20 kg/m(2); HR 0.94 (95% CI, 0.78-1.12) for BMI 25-30 kg/m(2); HR 1.55 (95% CI, 1.20-1.99) for BMI 30-35 kg/m(2); and HR 2.90 (95% CI, 1.92-4.37) for BMI ≥ 35 kg/m(2).
Conclusions: Obesity, particularly severe obesity, is strongly associated with hospitalization for HF in patients with type 1 diabetes, whereas no similar relation was present in overweight and low body weight.
Fridolfsson C, Thegerstrom J, Akesson K, Engvall J, Blomstrand P Sci Rep. 2024; 14(1):3982.
PMID: 38368449 PMC: 10874446. DOI: 10.1038/s41598-024-54597-6.
Body composition and metabolic syndrome in patients with type 1 diabetes.
Zeng Q, Chen X, He Y, Ma Z, Wu Y, Lin K World J Diabetes. 2024; 15(1):81-91.
PMID: 38313851 PMC: 10835494. DOI: 10.4239/wjd.v15.i1.81.
Body adiposity markers and insulin resistance in patients with type 1 diabetes.
Marques C, Beretta M, Prates R, de Almeida J, da Costa Rodrigues T Arch Endocrinol Metab. 2023; 67(3):401-407.
PMID: 36748935 PMC: 10247250. DOI: 10.20945/2359-3997000000599.
Genua I, Franch-Nadal J, Navas E, Mata-Cases M, Gimenez-Perez G, Vlacho B Front Endocrinol (Lausanne). 2022; 13:1015614.
PMID: 36531459 PMC: 9756841. DOI: 10.3389/fendo.2022.1015614.
Pastor-Fajardo M, Fajardo-Gimenez M, Bosch-Gimenez V, Pastor-Rosado J BMC Pediatr. 2022; 22(1):274.
PMID: 35549683 PMC: 9097405. DOI: 10.1186/s12887-022-03330-1.